Informacje dodatkowe
| Active substance | Febuxostat |
|---|---|
| Chemical name | 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
| Side effects | Liver function abnormalities, nausea, joint pain, rash |
| Effects | Decreases serum uric acid levels |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 40 mg or 80 mg once daily |
| Half-life | Approximately 5 to 8 hours |
| Main action | Reduces uric acid production |
| Substance class | Xanthine oxidase inhibitor |
| Formula | C16H16N2O3S |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Uloric |
| Blood pressure | No significant effect |
| Also known as | Febutaz, Adenuric |
| Strength | 40mg |
| Lab Test | Monitoring of uric acid levels, liver function tests |
| Hepatotoxicity | Possible, requires monitoring of liver function |
| Water Retention | No significant effect |
| Use in sports | Not typically used in sports |
| Manufacturer | Sun Pharma Laboratories Ltd. |
| Packing | 15 tabs/blister |
|
Opinie
Na razie nie ma opinii o produkcie.